Stains & CD markers
PAX2


Last author update: 1 November 2013
Last staff update: 29 July 2022

Copyright: 2002-2022, PathologyOutlines.com, Inc.

PubMed Search: PAX2

Nat Pernick, M.D.
Page views in 2021: 3,366
Page views in 2022 to date: 2,213
Cite this page: Pernick N. PAX2. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/stainspax2.html. Accessed August 11th, 2022.
Definition / general
  • Paired-box 2; nuclear transcription factor, structurally similar to PAX8 with virtually identical expression in nonneoplastic tissue
  • Essential in embryonic development of Müllerian organs and hindbrain
  • Suppressed through promoter methylation at later stages of embryonic development but is reactivated during carcinogenesis (J Cell Mol Med 2013;17:1048)
Clinical features
Uses by pathologists
Microscopic (histologic) images

Images hosted on other servers:
Missing Image

Kidney, multicystic dysplasia

Missing Image

Kidney, hemangioblastoma

Missing Image

Skin, nevi, melanoma

Missing Image

Kidney, fetal

Missing Image

Fallopian tube

Missing Image

Ovary, high grade carcinomas


Missing Image Missing Image Missing Image Missing Image

Uterus, endometrial intraepithelial neoplasia

Missing Image Missing Image

Bladder / GU: nephrogenic adenoma

Positive staining - normal
Positive staining - disease
Negative staining
  • Adenomatoid tumor
  • Bladder: clear cell adenocarcinoma (usually)
  • Kidney: angiomyolipoma with epithelial cysts and synovial sarcoma are negative but PAX2 and PAX8 often positive in epithelial cysts, likely due to entrapment and dilation of renal tubules (Am J Surg Pathol 2011;35:1264)
  • Kidney: carcinoid
  • Kidney: Ewing / PNET, neuroblastoma, T ALL
  • Mesothelioma (Appl Immunohistochem Mol Morphol 2012;20:272)
  • Testis: normal seminiferous tubules or interstitium; germ cell tumors, Leydig cell tumors, Sertoli cell tumors (Am J Surg Pathol 2011;35:1473)
  • Uterus: usually (71%) loss of PAX2 staining
Back to top
Image 01 Image 02